Clinical Trials Directory

Trials / Completed

CompletedNCT01061879

Expansion of Umbilical Cord Blood Using a Unique Bio-system

Ex Vivo Expansion of Umbilical Cord Blood Using a Unique Bio-system

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
University of Kansas · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

By doing this study, researchers hope to develop a special technique and laboratory conditions to help support umbilical stem cell growth and multiplication. In this project, researchers propose a three dimensional (3D) microenvironment that mimics the bone marrow stem cell microenvironment, with its supporting cells of osteoblasts and stromal cells. In theory, this will result in better expansion of cord blood stem cells ex vivo.

Detailed description

To successfully expand umbilical cord blood stem cells ex vivo, a microenvironment that resembles the stem cell microenvironment, or stem cell 'niche' should be created. In designing this bio-system, we make use of several observations. First, bone osteoblasts are important in promoting hematopoietic stem cell expansion, accordingly, this bio-system will ensure the physical proximity of the cord blood stem cells to a 3D bone tissue derived from mesenchymal stem cells (MSCs). These MSCs will be isolated from Wharton's jelly, and by using an osteogenic medium and special scaffolds, these MSCs will differentiate into osteogenic progenitors creating a 3D bone structure. The other observation is that, co-culture of cord blood stem cells with mesenchymal stem cells is superior to liquid cultures in terms of ex vivo expansion , accordingly, in this experiment, undifferentiated MSCs will be co-cultured with cord blood stem cells in this created 3D bone structure. This is a unique design that has the potential to expand cord blood stem cells more efficiently.

Conditions

Timeline

Start date
2010-02-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2010-02-03
Last updated
2013-01-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01061879. Inclusion in this directory is not an endorsement.